NCT00645632View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 1990

Primary Completion Date

January 31, 1995

Study Completion Date

January 31, 2008

Conditions
Sarcoma
Interventions
DRUG

cisplatin

DRUG

doxorubicin hydrochloride

DRUG

ifosfamide

DRUG

methotrexate

PROCEDURE

adjuvant therapy

PROCEDURE

neoadjuvant therapy

PROCEDURE

therapeutic conventional surgery

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT00645632 - Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma | Biotech Hunter | Biotech Hunter